NUTM1 and nut midline carcinoma: Importantly, for these reported non-classical cases, the tumors usually demonstrated an immunophenotype classic for NUT carcinoma: diffuse p63 and or p40 expression and speckled nuclear expression of NUT antibody in greater than 50% of tumor cells [3, 5].